Spruce Biosciences (SPRB) Assets (2019 - 2026)
Spruce Biosciences (SPRB) posted quarterly Assets of $56.2 million for Q1 2026, up 77.47% year-over-year from $31.6 million in Q1 2025, and up 5.93% quarter-over-quarter from $53.0 million in Q4 2025.
Spruce Biosciences (SPRB) Assets (2019 - 2026) Analysis & Trends
Spruce Biosciences (SPRB) has reported Assets for 8 consecutive years, with $56.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets rose 77.47% year-over-year to $56.2 million; the TTM figure through Mar 2026 stood at $56.2 million (up 77.47% YoY), while the FY2025 annual figure was $53.0 million, up 17.28% from the prior year.
- Assets grew to $56.2 million in Q1 2026 per SPRB's latest filing, from $53.0 million in the prior quarter.
- Across five years, Assets topped out at $139.1 million in Q1 2023 and bottomed at $15.3 million in Q3 2025.
- Historically, Assets has averaged $78.5 million across 5 years, with a median of $85.6 million in 2022.
- Annual changes were most pronounced in 2025 — Assets tumbled 76.48% — and 2026, when it surged 77.47%.
- Spruce Biosciences' Assets stood at $85.6 million in 2022, then advanced by 21.36% to $103.9 million in 2023, then sank by 56.51% to $45.2 million in 2024, then rose by 17.28% to $53.0 million in 2025, then grew by 5.93% to $56.2 million in 2026.
- Business Quant data shows SPRB's Assets at $56.2 million in Q1 2026, $53.0 million in Q4 2025, and $15.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Spruce Biosciences | 127.00 Mn | 127.00 Mn | - | 102.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 102.85 Mn |
| Mar 31, 2026 | 56.17 Mn |
| Dec 31, 2025 | 53.02 Mn |
| Sep 30, 2025 | 15.31 Mn |
| Jun 30, 2025 | 21.82 Mn |
| Mar 31, 2025 | 31.65 Mn |
| Dec 31, 2024 | 45.21 Mn |
| Sep 30, 2024 | 65.10 Mn |
| Jun 30, 2024 | 75.52 Mn |
| Mar 31, 2024 | 87.54 Mn |
| Dec 31, 2023 | 103.95 Mn |
| Sep 30, 2023 | 112.99 Mn |
| Jun 30, 2023 | 125.96 Mn |
| Mar 31, 2023 | 139.11 Mn |
| Dec 31, 2022 | 85.65 Mn |
| Sep 30, 2022 | 95.30 Mn |
| Jun 30, 2022 | 104.52 Mn |
| Mar 31, 2022 | 114.99 Mn |
| Dec 31, 2021 | 126.49 Mn |
| Sep 30, 2021 | 135.09 Mn |